These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D. Simbolo M; Mafficini A; Sikora KO; Fassan M; Barbi S; Corbo V; Mastracci L; Rusev B; Grillo F; Vicentini C; Ferrara R; Pilotto S; Davini F; Pelosi G; Lawlor RT; Chilosi M; Tortora G; Bria E; Fontanini G; Volante M; Scarpa A J Pathol; 2017 Mar; 241(4):488-500. PubMed ID: 27873319 [TBL] [Abstract][Full Text] [Related]
3. Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids. Fernandez-Cuesta L; Peifer M; Lu X; Sun R; Ozretić L; Seidal D; Zander T; Leenders F; George J; Müller C; Dahmen I; Pinther B; Bosco G; Konrad K; Altmüller J; Nürnberg P; Achter V; Lang U; Schneider PM; Bogus M; Soltermann A; Brustugun OT; Helland Å; Solberg S; Lund-Iversen M; Ansén S; Stoelben E; Wright GM; Russell P; Wainer Z; Solomon B; Field JK; Hyde R; Davies MP; Heukamp LC; Petersen I; Perner S; Lovly C; Cappuzzo F; Travis WD; Wolf J; Vingron M; Brambilla E; Haas SA; Buettner R; Thomas RK Nat Commun; 2014 Mar; 5():3518. PubMed ID: 24670920 [TBL] [Abstract][Full Text] [Related]
4. Gene Expression Profiling of Lung Atypical Carcinoids and Large Cell Neuroendocrine Carcinomas Identifies Three Transcriptomic Subtypes with Specific Genomic Alterations. Simbolo M; Barbi S; Fassan M; Mafficini A; Ali G; Vicentini C; Sperandio N; Corbo V; Rusev B; Mastracci L; Grillo F; Pilotto S; Pelosi G; Pelliccioni S; Lawlor RT; Tortora G; Fontanini G; Volante M; Scarpa A; Bria E J Thorac Oncol; 2019 Sep; 14(9):1651-1661. PubMed ID: 31085341 [TBL] [Abstract][Full Text] [Related]
5. Transcriptomic profiles of myxofibrosarcoma and undifferentiated pleomorphic sarcoma correlate with clinical and genomic features. Mitra S; Farswan A; Piccinelli P; Sydow S; Hesla A; Tsagkozis P; Vult von Steyern F; Almqvist M; Eriksson M; Magnusson L; Nilsson J; Pillay N; Mertens F J Pathol; 2024 Nov; 264(3):293-304. PubMed ID: 39258383 [TBL] [Abstract][Full Text] [Related]
7. Specific Genomic Alterations in High-Grade Pulmonary Neuroendocrine Tumours with Carcinoid Morphology. Cros J; Théou-Anton N; Gounant V; Nicolle R; Reyes C; Humez S; Hescot S; Thomas de Montpréville V; Guyétant S; Scoazec JY; Guyard A; de Mestier L; Brosseau S; Mordant P; Castier Y; Gentien D; Ruszniewski P; Zalcman G; Couvelard A; Cazes A Neuroendocrinology; 2021; 111(1-2):158-169. PubMed ID: 32015233 [TBL] [Abstract][Full Text] [Related]
8. Genomic and transcriptomic characterisation of undifferentiated pleomorphic sarcoma of bone. Ali NM; Niada S; Brini AT; Morris MR; Kurusamy S; Alholle A; Huen D; Antonescu CR; Tirode F; Sumathi V; Latif F J Pathol; 2019 Feb; 247(2):166-176. PubMed ID: 30281149 [TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine tumours of the breast: a genomic comparison with mucinous breast cancers and neuroendocrine tumours of other anatomic sites. Pareja F; Vahdatinia M; Marchio C; Lee SSK; Da Cruz Paula A; Derakhshan F; da Silva EM; Selenica P; Dopeso H; Chandarlapaty S; Wen HY; Vincent-Salomon A; Brogi E; Weigelt B; Reis-Filho JS J Clin Pathol; 2022 Jan; 75(1):10-17. PubMed ID: 33148628 [TBL] [Abstract][Full Text] [Related]
10. Drivers underpinning the malignant transformation of giant cell tumour of bone. Fittall MW; Lyskjaer I; Ellery P; Lombard P; Ijaz J; Strobl AC; Oukrif D; Tarabichi M; Sill M; Koelsche C; Mechtersheimer G; Demeulemeester J; Tirabosco R; Amary F; Campbell PJ; Pfister SM; Jones DT; Pillay N; Van Loo P; Behjati S; Flanagan AM J Pathol; 2020 Dec; 252(4):433-440. PubMed ID: 32866294 [TBL] [Abstract][Full Text] [Related]
11. Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities. Swarts DR; Ramaekers FC; Speel EJ Biochim Biophys Acta; 2012 Dec; 1826(2):255-71. PubMed ID: 22579738 [TBL] [Abstract][Full Text] [Related]
12. Multiomics sequencing and immune microenvironment characteristics define three subtypes of small cell neuroendocrine carcinoma of the cervix. Pan B; Yan S; Yuan L; Xiang H; Ju M; Xu S; Jia W; Li J; Zhao Q; Zheng M J Pathol; 2024 Jul; 263(3):372-385. PubMed ID: 38721894 [TBL] [Abstract][Full Text] [Related]
13. TTF-1 expression is specific for lung primary in typical and atypical carcinoids: TTF-1-positive carcinoids are predominantly in peripheral location. Du EZ; Goldstraw P; Zacharias J; Tiffet O; Craig PJ; Nicholson AG; Weidner N; Yi ES Hum Pathol; 2004 Jul; 35(7):825-31. PubMed ID: 15257545 [TBL] [Abstract][Full Text] [Related]
14. Transcriptomic data helps refining classification of pulmonary carcinoid tumors with increased mitotic counts. Sazonova O; Manem V; Orain M; Khoshkrood-Mansoori B; Gaudreault N; Desmeules P; Bossé Y; Joubert P Mod Pathol; 2020 Sep; 33(9):1712-1721. PubMed ID: 32291397 [TBL] [Abstract][Full Text] [Related]
15. An in-silico analysis reveals further evidence of an aggressive subset of lung carcinoids sharing molecular features of high-grade neuroendocrine neoplasms. Pelosi G; Melocchi V; Dama E; Hofman P; De Luca M; Albini A; Gemelli M; Ricotta R; Papotti M; La Rosa S; Uccella S; Harari S; Sonzogni A; Asiedu MK; Wigle DA; Bianchi F Exp Mol Pathol; 2024 Feb; 135():104882. PubMed ID: 38237798 [TBL] [Abstract][Full Text] [Related]
16. Pathways Impacted by Genomic Alterations in Pulmonary Carcinoid Tumors. Asiedu MK; Thomas CF; Dong J; Schulte SC; Khadka P; Sun Z; Kosari F; Jen J; Molina J; Vasmatzis G; Kuang R; Aubry MC; Yang P; Wigle DA Clin Cancer Res; 2018 Apr; 24(7):1691-1704. PubMed ID: 29351916 [No Abstract] [Full Text] [Related]
17. Gene expression profiling reveals GC and CEACAM1 as new tools in the diagnosis of lung carcinoids. Toffalorio F; Belloni E; Barberis M; Bucci G; Tizzoni L; Pruneri G; Fumagalli C; Spitaleri G; Catania C; Melotti F; Pelicci PG; Spaggiari L; De Pas T Br J Cancer; 2014 Mar; 110(5):1244-9. PubMed ID: 24518592 [TBL] [Abstract][Full Text] [Related]
18. Integrative molecular characterisation of gallbladder cancer reveals micro-environment-associated subtypes. Nepal C; Zhu B; O'Rourke CJ; Bhatt DK; Lee D; Song L; Wang D; Van Dyke AL; Choo-Wosoba H; Liu Z; Hildesheim A; Goldstein AM; Dean M; LaFuente-Barquero J; Lawrence S; Mutreja K; Olanich ME; Lorenzo Bermejo J; ; Ferreccio C; Roa JC; Rashid A; Hsing AW; Gao YT; Chanock SJ; Araya JC; Andersen JB; Koshiol J J Hepatol; 2021 May; 74(5):1132-1144. PubMed ID: 33276026 [TBL] [Abstract][Full Text] [Related]
19. Differential Orthopedia Homeobox expression in pulmonary carcinoids is associated with changes in DNA methylation. Moonen L; Mangiante L; Leunissen DJG; Lap LMV; Gabriel A; Hillen LM; Roemen GM; Koch A; van Engeland M; Dingemans AC; Foll M; Alcala N; Fernandez-Cuesta L; Derks JL; Speel EM Int J Cancer; 2022 Jun; 150(12):1987-1997. PubMed ID: 35076935 [TBL] [Abstract][Full Text] [Related]
20. Comprehensive Characterization of the Genomic Landscape in Chinese Pulmonary Neuroendocrine Tumors Reveals Prognostic and Therapeutic Markers (CSWOG-1901). Peng W; Cao L; Chen L; Lin G; Zhu B; Hu X; Lin Y; Zhang S; Jiang M; Wang J; Li J; Li C; Shao L; Du H; Hou T; Chen Z; Xiang J; Pu X; Li J; Xu F; Loong H; Wu L Oncologist; 2022 Mar; 27(2):e116-e125. PubMed ID: 35641209 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]